4.7 Article

Effect of Preoperative Immunonutrition on Postoperative Major Morbidity after Cytoreductive Surgery and HIPEC in Patients with Peritoneal Metastasis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Surgery

Impact of Oral Immunonutrition on Postoperative Morbidity in Digestive Oncologic Surgery A Nation-wide Cohort Study

Alexandre Challine et al.

Summary: The study, based on a nationwide dataset, found that preoperative immunonutrition did not significantly reduce postoperative morbidity or mortality, but was associated with shorter length of hospital stay.

ANNALS OF SURGERY (2021)

Article Oncology

Prehabilitation of patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal malignancy

Delia Cortes-Guiral et al.

Summary: Prehabilitation is a multimodal approach that helps optimize postoperative recovery and reduce morbidity in patients undergoing treatment for peritoneal malignancy.
Article Oncology

Predictive Ability of C-Reactive Protein in Detecting Short-Term Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Retrospective Cross-Sectional Study

Job P. van Kooten et al.

Summary: This study analyzed the predictive value of postoperative inflammatory biomarkers CRP and WBC in assessing complications after CRS and HIPEC. The results indicated that patients with continuously increasing CRP levels from the second to fifth postoperative day were more likely to develop SAE >= 3 complications. CRP concentrations above 166 mg/L on POD3 and 116 mg/L on POD4 were associated with the highest risk of SAE >= 3, while postoperative WBC levels did not show significant differences between patients with different SAE levels.

ANNALS OF SURGICAL ONCOLOGY (2021)

Article Oncology

Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial

Francois Quenet et al.

Summary: This study aimed to evaluate the specific benefit of adding hyperthermic intraperitoneal chemotherapy (HIPEC) to cytoreductive surgery compared with receiving cytoreductive surgery alone in patients with colorectal peritoneal metastases. The results showed no significant overall survival benefit after adding HIPEC, with more frequent postoperative late complications, suggesting that cytoreductive surgery alone should be prioritized as a treatment strategy.

LANCET ONCOLOGY (2021)

Review Gastroenterology & Hepatology

Effect of Perioperative Nutritional Supplementation on Postoperative Complications-Systematic Review and Meta-Analysis

Betty Zhang et al.

JOURNAL OF GASTROINTESTINAL SURGERY (2019)

Article Medicine, General & Internal

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer

W. J. van Driel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Gastroenterology & Hepatology

Preoperative Immunonutrition and Elective Colorectal Resection Outcomes

Lucas W. Thornblade et al.

DISEASES OF THE COLON & RECTUM (2017)

Review Gastroenterology & Hepatology

Should perioperative immunonutrition for elective surgery be the current standard of care?

Shishira Bharadwaj et al.

GASTROENTEROLOGY REPORT (2016)

Review Oncology

Complications of Cytoreductive Surgery and HIPEC in the Treatment of Peritoneal Metastases

Sanket S. Mehta et al.

INDIAN JOURNAL OF SURGICAL ONCOLOGY (2016)

Article Critical Care Medicine

Immunosupression and Infection After Major Surgery: A Nutritional Deficiency

Xinmei Zhu et al.

CRITICAL CARE CLINICS (2010)